Buy Lineage Cell Therapeutics Inc Stock | LCTX Stock Price & Latest News | Public
LCTX

Lineage Cell Therapeutics Inc

$0.00 (0.00%)Today
    Small Market Cap

    About LCTX

    Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The comp...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.02
    -0.04
    -0.06
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.05

    Actual EPS
    Q3 2020

    Stats

    Market Cap$137,96M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$1.67
    1 Year Low$0.53
    Open$0.92
    High$0.94
    Low$0.86

    Buy any stock with any amount of money.

    Download the App
    Download the app